askbio

Asklepios BioPharmaceutical, Inc., a Research Triangle Park, NC-based clinical-stage adeno-associated virus (AAV) gene therapy company, acquired BrainVectis, a Paris, France-based gene therapy company and French National Institute for Health and Medical Research (INSERM) spin-out with expertise and an intellectual property estate for the treatment of neurodegenerative disorders.